Disproportionality analysis of adverse events signals associated with laronidase and idursulfase based on the FDA adverse event reporting system database

doi:10.3969/j.issn.1672-3384.2026.04.013

Ruixue ZHANG, Ximu SUN, Han ZHOU, Haiting CHENG, Ying LIU

Clinical Medication Journal ›› 2026, Vol. 24 ›› Issue (4) : 67-73.

PDF(453 KB)

Clinical Medication Journal ›› 2026, Vol. 24 ›› Issue (4) : 67-73. DOI: 10.3969/j.issn.1672-3384.2026.04.013

Original Article

Disproportionality analysis of adverse events signals associated with laronidase and idursulfase based on the FDA adverse event reporting system database

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 24(4): 67-73 https://doi.org/10.3969/j.issn.1672-3384.2026.04.013

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(453 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2025-06-04	2026-04-25
Issue Date
2026-04-28

Please choose a citation manager

Content to export